Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Cullinan Therapeutics logo

Cullinan Therapeutics

Recent Finacing

Series C

Recent Raise

$131.2M

Cullinan Oncology assembles and advances a diversified portfolio of internally developed and externally sourced oncology and immuno-oncology assets using centralized management and shared-services for single-asset development.

Founded 2017
Massachusetts, United States
11-50
Publicly Traded
cullinanoncology.com

Highlights

Focus Areas

Biopharma
Biotechnology
Medical Device
Oncology

Recent Investors

F2 Ventures logo
MPM Capital logo
UBS logo
Schooner Capital logo
Baupost Group logo
Foresite Capital logo
Eventide Asset Management logo
Logos Capital logo
BVF Partners logo
Boxer Capital logo
Leerink Partners logo
Venrock logo

Financials

$379.7M

Total Raised

3

Funding rounds

16

Investors


Team

Upgrade to view the team

See the team members at Cullinan Therapeutics.